Advertisement

Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly

Published:October 19, 2017DOI:https://doi.org/10.1016/j.amjcard.2017.10.017
      We sought to describe the acute results and short- to medium-term durability of transcatheter tricuspid valve-in-valve (TVIV) implantation within surgical bioprostheses among patients with Ebstein anomaly (EA). Cases were identified from a voluntary, multicenter, international registry of 29 institutions that perform TVIV. Demographic, clinical, procedural, and follow-up data were analyzed. Eighty-one patients with EA underwent TVIV from 2008 to 2016. Thirty-four patients (42%) were New York Heart Association (NYHA) class 3/4 at time of TVIV. The most common indication for TVIV was the presence of moderate or severe tricuspid regurgitation (40%). Most patients received a Melody valve (64%). TVIV was ultimately successful in all patients, and there was no procedural mortality. Four patients (5%) developed acute valve thrombosis, 4 patients (5%) developed endocarditis, and 9 patients (11%) developed valve dysfunction not related to thrombosis or endocarditis. Eight patients (10%) underwent reintervention (2 transcatheter, 6 surgical) due to thrombosis (3), endocarditis (2), other valve dysfunction (2), and patient-prosthesis mismatch without valve dysfunction (1). Among 69 patients who were alive without reintervention at latest follow-up, 96% of those with NYHA status reported were class 1/2, a significant improvement from baseline (62% NYHA class 1/2, p <0.001). In conclusion, transcatheter TVIV offers a low-risk, minimally invasive alternative to surgical tricuspid valve re-replacement in patients with EA and a failing tricuspid valve bioprosthesis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brown M.L.
        • Dearani J.A.
        • Danielson G.K.
        • Cetta F.
        • Connolly H.M.
        • Warnes C.A.
        • Li Z.
        • Hodge D.O.
        • Driscoll D.J.
        The outcomes of operations for 539 patients with Ebstein anomaly.
        J Thorac Cardiovasc Surg. 2008; 135: 1120-1136
        • Brown M.L.
        • Dearani J.A.
        • Danielson G.K.
        • Cetta F.
        • Connolly H.M.
        • Warnes C.A.
        • Li Z.
        • Hodge D.O.
        • Driscoll D.J.
        Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly.
        Am J Cardiol. 2009; 103: 555-561
        • Filsoufi F.
        • Anyanwu A.C.
        • Salzberg S.P.
        • Frankel T.
        • Cohn L.H.
        • Adams D.H.
        Long-term outcomes of tricuspid valve replacement in the current era.
        Ann Thorac Surg. 2005; 80: 845-850
        • Chang B.C.
        • Lim S.H.
        • Yi G.
        • Hong Y.S.
        • Lee S.
        • Yoo K.J.
        • Kang M.S.
        • Cho B.K.
        Long-term clinical results of tricuspid valve replacement.
        Ann Thorac Surg. 2006; 81: 1317-1323
        • Moraca R.J.
        • Moon M.R.
        • Lawton J.S.
        • Guthrie T.J.
        • Aubuchon K.A.
        • Moazami N.
        • Pasque M.K.
        • Damiano R.J.
        Outcomes of tricuspid valve repair and replacement: a propensity analysis.
        Ann Thorac Surg. 2009; 87: 83-88
        • van Slooten Y.J.
        • Freling H.G.
        • van Melle J.P.
        • Mulder B.J.
        • Jongbloed M.R.
        • Ebels T.
        • Voors A.A.
        • Pieper P.G.
        Long-term tricuspid valve prosthesis-related complications in patients with congenital heart disease.
        Eur J Cardiothorac Surg. 2014; 45: 83-89
        • Ruparelia N.
        • Mangieri A.
        • Ancona M.
        • Giannini F.
        • Agricola E.
        • Montorfano M.
        • De Bonis M.
        • Alfieri O.
        • Colombo A.
        • Latib A.
        Percutaneous transcatheter treatment for tricuspid bioprosthesis failure.
        Catheter Cardiovasc Interv. 2016; 88: 994-1001
        • Eicken A.
        • Schubert S.
        • Hager A.
        • Hörer J.
        • McElhinney D.B.
        • Hess J.
        • Ewert P.
        • Berger F.
        Percutaneous tricuspid valve implantation: two-center experience with midterm results.
        Circ Cardiovasc Interv. 2015; 8: e002155
        • Tzifa A.
        • Momenah T.
        • Al Sahari A.
        • Al Khalaf K.
        • Papagiannis J.
        • Qureshi S.A.
        Transcatheter valve-in-valve implantation in the tricuspid position.
        EuroIntervention. 2014; 10: 995-999
        • Cunnington C.
        • Hoschtitzky J.A.
        • Hasan R.
        • Clarke B.
        • Mahadevan V.S.
        Percutaneous tricuspid valve-in-valve implantation in Ebstein's anomaly: one-year follow-up of valve function.
        Int J Cardiol. 2014; 174: e77-e78
        • Hanna B.M.
        • Rodes-Cabau J.
        • Dahdah N.
        Percutaneous transcatheter valve-in-valve implantation with the balloon-expandable valve for the treatment of a dysfunctional tricuspid bioprosthetic valve: a pediatric case report.
        J Invasive Cardiol. 2013; 25: 310-312
        • Cullen M.W.
        • Cabalka A.K.
        • Alli O.O.
        • Pislaru S.V.
        • Sorajja P.
        • Nkomo V.T.
        • Malouf J.F.
        • Cetta F.
        • Hagler D.J.
        • Rihal C.S.
        Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults.
        JACC Cardiovasc Interv. 2013; 6: 598-605
        • Van Garsse L.A.
        • Ter Bekke R.M.
        • van Ommen V.G.
        Percutaneous transcatheter valve-in-valve implantation in stenosed tricuspid valve bioprosthesis.
        Circulation. 2011; 123: e219-e221
        • Roberts P.A.
        • Boudjemline Y.
        • Cheatham J.P.
        • Eicken A.
        • Ewert P.
        • McElhinney D.B.
        • Hill S.L.
        • Berger F.
        • Khan D.
        • Schranz D.
        • Hess J.
        • Ezekowitz M.D.
        • Celermajer D.
        • Zahn E.
        Percutaneous tricuspid valve replacement in congenital and acquired heart disease.
        J Am Coll Cardiol. 2011; 58: 117-122
        • McElhinney D.B.
        • Cabalka A.K.
        • Aboulhosn J.A.
        • Eicken A.
        • Boudjemline Y.
        • Schubert S.
        • Himbert D.
        • Asnes J.D.
        • Salizzoni S.
        • Bocks M.L.
        • Cheatham J.P.
        • Momenah T.S.
        • Kim D.W.
        • Schranz D.
        • Meadows J.
        • Thomson J.D.
        • Goldstein B.H.
        • Crittendon 3rd, I.
        • Fagan T.E.
        • Webb J.G.
        • Horlick E.
        • Delaney J.W.
        • Jones T.K.
        • Shahanavaz S.
        • Moretti C.
        • Hainstock M.R.
        • Kenny D.P.
        • Berger F.
        • Rihal C.S.
        • Dvir D.
        Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study.
        Circulation. 2016; 133: 1582-1593
        • Latib A.
        • Naganuma T.
        • Abdel-Wahab M.
        • Danenberg H.
        • Cota L.
        • Barbanti M.
        • Baumgartner H.
        • Finkelstein A.
        • Legrand V.
        • de Lezo J.S.
        • Kefer J.
        • Messika-Zeitoun D.
        • Richardt G.
        • Stabile E.
        • Kaleschke G.
        • Vahanian A.
        • Laborde J.C.
        • Leon M.B.
        • Webb J.G.
        • Panoulas V.F.
        • Maisano F.
        • Alfieri O.
        • Colombo A.
        Treatment and clinical outcomes of transcatheter heart valve thrombosis.
        Circ Cardiovasc Interv. 2015; 8: e001779
        • Schneider A.E.
        • Delaney J.W.
        • Cabalka A.K.
        Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
        Catheter Cardiovasc Interv. 2016; 88: 600-604
        • Egbe A.C.
        • Pislaru S.V.
        • Pellikka P.A.
        • Poterucha J.T.
        • Schaff H.V.
        • Maleszewski J.J.
        • Connolly H.M.
        Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors.
        J Am Coll Cardiol. 2015; 66: 2285-2294
        • Nishimura R.A.
        • Otto C.M.
        • Bonow R.O.
        • Carabello B.A.
        • Erwin 3rd, J.P.
        • Guyton R.A.
        • O'Gara P.T.
        • Ruiz C.E.
        • Skubas N.J.
        • Sorajja P.
        • Sundt T.M.
        2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2014; 129: e521-e643
        • Bentham J.
        • Qureshi S.
        • Eicken A.
        • Gibbs J.
        • Ballard G.
        • Thomson J.
        Early percutaneous valve failure within bioprosthetic tricuspid tissue valve replacements.
        Catheter Cardiovasc Interv. 2013; 82: 428-435
        • Jeganathan R.
        • Armstrong S.
        • Al-Alao B.
        • David T.
        The risk and outcomes of reoperative tricuspid valve surgery.
        Ann Thorac Surg. 2013; 95: 119-124